NR AOAL
AU Verbeek,M.M.; De Jong,D.; Kremer,H.P.
TI Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases
QU Annals of Clinical Biochemistry 2003 Jan; 40(1): 25-40
PT journal article; review; review, academic
AB Neurodegenerative disorders have traditionally been classified according to clinical criteria, e.g. as dementia syndromes (the best known is Alzheimer's disease) or as movement disorders (e.g. Parkinson's disease). Another subdivision is based on recent insights into the respective pathogenetic mechanisms, leading to the recognition of so-called tauopathies and alpha-synucleinopathies. It is this increased knowledge of the underlying (neuro)pathological mechanisms that has sparked interest in studies aimed at the identification of disease-specific biomarkers in cerebrospinal fluid (CSF) for this field of neurological disorders. This review deals with the recent progress that has been made in identification, quantification and subsequent validation of brain-specific proteins in CSF for the diagnosis of various neurodegenerative disorders. Development of disease-specific CSF biomarkers will undoubtedly add to the process of differential diagnosis early in the course of the disease.
ZR 121
MH Alleles; Alzheimer Disease/cerebrospinal fluid/diagnosis; Amyloid beta-Protein/cerebrospinal fluid; Apolipoproteins E/metabolism; Brain/*metabolism/*pathology; Calcium-Binding Proteins/cerebrospinal fluid; Creutzfeldt-Jakob Syndrome/cerebrospinal fluid/diagnosis; Glial Fibrillary Acidic Protein/cerebrospinal fluid; Human; Nerve Growth Factors/cerebrospinal fluid; Nerve Tissue Proteins/cerebrospinal fluid; Neurodegenerative Diseases/*cerebrospinal fluid/*diagnosis; Neurofilament Proteins/cerebrospinal fluid; Phosphopyruvate Hydratase/cerebrospinal fluid; Phosphorylation; S100 Proteins/cerebrospinal fluid; tau Proteins/cerebrospinal fluid
AD Department of Neurology, 319 LKN, PO Box 9101, 6500 HB Nijmegen, The Netherlands.
SP englisch
PO England